Advancements in Targeted Lung Cancer Therapies

This chapter explores the complexities and advancements in treating lung cancer patients with targetable mutations, particularly focusing on the evolving strategies in immunotherapy and combination therapies. It discusses promising new treatments, including bispecific antibodies and the significance of patient stratification in clinical trials. The conversation further delves into emerging challenges and potential strategies for enhancing treatment outcomes in difficult-to-treat lung cancer subtypes.